| Vol. 14.44 – 25 November, 2020 |
| |
|
|
| Researchers showed that BACE pharmacological inhibition ameliorates β-site APP-cleaving enzyme 1 (BACE1) axonal trafficking and diminishes axonal dystrophies in Gga3 null neurons in vitro and in vivo. [Science Translational Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Using viral tracing and whole-brain imaging, investigators reconstructed the three-dimensional architecture of the hypothalamo-neurohypophysial system and observed collaterals of magnocellular neuroendocrine cells within the brain. [Neuron] |
|
|
|
| ATP6V1A was identified as a key regulator of a top-ranked neuronal subnetwork, and its role in disease-related processes was evaluated through CRISPR-based manipulation in human induced pluripotent stem cell-derived neurons and RNAi-based knockdown in Drosophila models. [Neuron] |
|
|
|
| Scientists overcame size barriers by combining high-resolution optical recordings of membrane potential, exocytosis, and Ca2+ in cultured hippocampal neurons. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Investigators showed that within demyelinating lesions, astrocyte circadian clocks produced the Wnt inhibitors SFRP1 and SFRP5. Unexpectedly, SFRP1 and SFRP5 signaled to the subventricular zone (SVZ) to reduce the circadian transcription factor BMAL1. This sequence of events caused adult neural stem cells in the SVZ to differentiate into oligodendrocyte lineage cells, which were then supplied to demyelinated lesions. [Cell Reports] |
|
|
|
| A screen of 1120 FDA-approved drugs identified 129 candidates that delayed the dissolution of hypoxia-induced stress granules (SGs) following a return to normoxia. Amongst these candidates, the selective estrogen receptor modulator raloxifene delayed SG dissolution in a dose-dependent manner. [Cell Death & Disease] |
|
|
|
| In a hypoxic microenvironment, the hypoxia-inducible factor 1α (HIF1α)/HIF2α-miR210-3p network promoted the malignant progression of glioblastoma through a positive feedback loop with epidermal growth factor (EGF). [Cell Death & Disease] |
|
|
|
| The authors tested if Receptor Protein Tyrosine Phosphatase (RPTP)/ζ was involved in the modulation of neuroinflammatory responses using specific inhibitors of RPTPβ/ζ. [Scientific Reports] |
|
|
|
| Researchers conducted comparative transcriptome analysis of mouse periventricular endothelial cells vs. adult brain endothelial cells in mono-culture or neural progenitor cells co-culture. [Scientific Reports] |
|
|
|
|
| The author review the current understanding of the changes in the activity of cerebellar Purkinje cells in different ‘microzones’ during various forms of learning. In addition, describes an emerging model that indicates that the activity of each microzone is bound to either increase or decrease during the initial stages of learning, depending on the directional and temporal demands of its downstream circuitry and the behavior involved. [Nature Reviews Neuroscience] |
|
|
|
| Scientists focus on recent findings on extracellular vesicle-mediated bilateral crosstalk, between glioblastoma cells and astrocytes, highlighting the protumor and antitumor roles of astrocytes in glioblastoma development. [Trends in Neuroscience] |
|
|
|
|
|
| Alzprotect annouced that the United States Patent and Trademark Office granted patent number US 10,772,884 concerning the therapeutic uses of its first-in-class clinical stage drug Ezeprogind in the treatment of tauopathies. [Alzprotect] |
|
|
|
|
| January 11 – January 13, 2021 Virtual |
|
|
|
|
|
|
| Genentech, Inc. – South San Francisco, California, United States |
|
|
|
| Imperial College London – London, England, United Kingdom |
|
|
|
| Max Planck Florida Institute for Neuroscience – Jupiter, Florida, United States |
|
|
|
| The University of Texas Health Science Center at San Antonio – San Antonio, Texas, United States |
|
|
|
| The University of Texas Health Science Center at San Antonio – San Antonio, Texas, United States |
|
|
|
|